ArticleBMC immunology2021
The augment of regulatory T cells undermines the efficacy of anti-PD-L1 treatment in cervical cancer.
Fengying Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
ArticleBMC immunology2021
Fengying Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.